My moonshot was/is the Covid-19 recovery stocks.
Back in March, I looked at individual companies beaten down by the lockdowns. I set up a screen, where I checked that their -66% or greater drop was timed with the outbreak (dropping in steps, like the US market, in March). Some companies might not make it, so I screened for indebtedness with debt/equity ratio. Then I bought dozens of stocks from different areas... and waited.
Some stocks recovered rapidly off the depths of the March panic, but there was still an uncertain amount of time left until these stocks recovered or went bankrupt. After being approved for options trading, I switched many of my positions from individual stocks, to call options on those same stocks. So that's where I'm at now.
Dine Brand's stock (DIN) doubled quickly after I bought it, so I wound up selling it.
One of my most entertaining purchases was MicroVision (MVIS) which I bought at a low of $0.20/share. At some point, a group on github analyzed patents and realized both MVIS and Microsoft patents were intertwined, suggesting Microsoft was the big customer MVIS wasn't allowed to disclose. The stock shot up rapidly after that, and I sold for an 8x-9x profit. That was also one of the rare times where I saw the name "Renaissance Technologies" listed as a significant shareholder.
I originally bought Macy's stock, but later switched to long-dated call options. In a bankruptcy, I figured stock and options both go to $0. Options provided leverage and/or reducing the amount of money I have at risk.
In the Oil Investments thread I mentioned XOP call options, which is the best way to go with the oil sector. Unlike individual companies that go bankrupt, XOP is an ETF with a variety of holdings. I had 2 oil stocks go bankrupt, both small individual companies... and I only bought 4 oil stocks, so that's saying something.
I bought call options on Carnival Cruises, which probably had the most spectacular day when the vaccine was announced with 95% effectiveness. In part of one day, the options were up +100%, and then slid down to +70% or so. You see that somewhat reflected in the stock, up +33% in 1 month, but still -55% YTD. I haven't sold yet - I expect more gains as vaccinations become widespread, and a recovery grows more likely.
We'll see...